Clinical Trial Research
Research Report on BioClinica, Inc. as Speculative Buy
Published in Drug Law Weekly, December 8th, 2009
Intellivest Securities Research, Inc., ("ISR") a Georgia registered investment advisor, has published a Report on BioClinica, Inc. (NASDAQ:BIOC) which serves companies in the pharmaceutical, biotechnology and medical device industries. A primary service is helping their clients manage, process and submit medical imaging portions of their submissions relating to their clinical trials to regulators, primarily the U.S. Food and Drug Administration and comparable European agencies, to evaluate product efficacy and safety. BioClinica has provided services to more than 130 firms in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2009-12-08)
More Articles from Drug Law Weekly
- A.P. Pharma, Inc.
A.P. Pharma Receives Notice of Compliance with Nasdaq Continued Listing Requirements - Antibiotics
New antibiotics study results from K. Miliani et al described - Bowman and Brooke Llp
Bowman and Brooke Opening Seventh Office in South Carolina - Clinical Trial Research
Studies from University of Houston provide new data on clinical trial research - Elhuyar Fundazioa
Research and legislation should go hand in hand, as much as possible - Hagens Berman Sobol Shapiro
U.S. Court of Appeals Upholds AstraZeneca AWP Settlement - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
